TapewireFind a company

person · Reporting owner

Zerhouni Elias A.

Disclosed activity across 2 companies

Tapewire entity
14367
SEC CIK
0001478398

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
DANAHER CORP /DE/DHR · Entity 2871DirectorJuly 31, 2026August 04, 2026
OPKO HEALTH, INC.OPK · Entity 4891Director · Vice Chairman and PresidentMay 27, 2025May 29, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

DANAHER CORP /DE/

Report date July 31, 2026 · Filed August 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom sharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct18,708.915 Reported balance After 2026-07-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-07-31 · Grant · Acquired 236.633 · Balance 18,708.915

F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3: The reporting person is fully vested in all amounts deferred under the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3: The reporting person is fully vested in all amounts deferred under the Plan.

OPKO HEALTH, INC.

Report date May 27, 2025 · Filed May 29, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.31 · Expires 2035-05-26Direct500,000 Reported balance After 2025-05-27 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-05-27 · Grant · Acquired 500,000 · Balance 500,000

F1: This option will vest in four equal annual installments beginning May 27, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: This option will vest in four equal annual installments beginning May 27, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 31, 2026 Filed Aug 4, 2026 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 236.633 $194.98 Strike: $0.00 $46,138.70
Disclosure

SEC source: 0000313616-26-000170 · wk-form4_1785877270.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,708.915

Underlying: Common Stock · 236.633 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees they are entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

Read SEC document
July 15, 2026 Filed Jul 16, 2026 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionDirector stock option (right to buy) · Derivative 3,298 $0.00 Strike: $71.88 $0.00
Disclosure

SEC source: 0000313616-26-000157 · wk-form4_1784235642.xml · derivative · entry 4

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,298 shares

Expires 2026-07-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 15, 2026 Filed Jul 16, 2026 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 Tax withholdingCommon Stock 1,181 $200.79 $237,132.99
Disclosure

SEC source: 0000313616-26-000157 · wk-form4_1784235642.xml · nonDerivative · entry 2

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,303.282

Read SEC document
July 15, 2026 Filed Jul 16, 2026 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionCommon Stock 3,298 $71.88 $237,060.24
Disclosure

SEC source: 0000313616-26-000157 · wk-form4_1784235642.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,484.282

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2026 Filed May 19, 2026 21:09 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,699 $0.00 Strike: $161.91 $0.00
Disclosure

SEC source: 0000313616-26-000141 · wk-form4_1779224973.xml · derivative · entry 3

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,699

Underlying: Common Stock · 1,699 shares

Expires 2036-05-15

Read SEC document
May 15, 2026 Filed May 19, 2026 21:09 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 680 $0.00 $0.00
Disclosure

SEC source: 0000313616-26-000141 · wk-form4_1779224973.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,186.282

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 24, 2026 Filed Apr 28, 2026 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 259.718 $177.25 Strike: $0.00 $46,035.02
Disclosure

SEC source: 0000313616-26-000120 · wk-form4_1777410048.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,472.282

Underlying: Common Stock · 259.718 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
January 30, 2026 Filed Feb 3, 2026 22:26 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 200.506 $218.89 Strike: $0.00 $43,888.76
Disclosure

SEC source: 0000313616-26-000015 · wk-form4_1770157571.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,212.564

Underlying: Common Stock · 200.506 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
October 31, 2025 Filed Nov 3, 2025 22:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 203.472 $215.38 Strike: $0.00 $43,823.80
Disclosure

SEC source: 0000313616-25-000193 · wk-form4_1762207269.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,012.058

Underlying: Common Stock · 203.472 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 25, 2025 Filed Jul 28, 2025 21:07 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 212.943 $205.48 Strike: $0.00 $43,755.53
Disclosure

SEC source: 0000313616-25-000170 · wk-form4_1753736862.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,808.586

Underlying: Common Stock · 212.943 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionDirector stock option (right to buy) · Derivative 3,928 $0.00 Strike: $59.34 $0.00
Disclosure

SEC source: 0000313616-25-000148 · wk-form4_1752699685.xml · derivative · entry 4

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,928 shares

Expires 2025-07-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 15, 2025 Filed Jul 16, 2025 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 Tax withholdingCommon Stock 1,209 $192.86 $233,167.74
Disclosure

SEC source: 0000313616-25-000148 · wk-form4_1752699685.xml · nonDerivative · entry 2

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,804.643

Read SEC document
July 15, 2025 Filed Jul 16, 2025 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionCommon Stock 3,928 $59.34 $233,087.52
Disclosure

SEC source: 0000313616-25-000148 · wk-form4_1752699685.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,013.643

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2025 Filed May 29, 2025 21:05 UTC OPKO HEALTH, INC. OPK · Entity 4891 GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $1.31 $0.00
Disclosure

SEC source: 0000950170-25-079115 · ownership.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2035-05-26

F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 27, 2026.

Read SEC document
May 15, 2025 Filed May 19, 2025 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,478 $0.00 Strike: $190.95 $0.00
Disclosure

SEC source: 0000313616-25-000129 · wk-form4_1747688454.xml · derivative · entry 3

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,478

Underlying: Common Stock · 1,478 shares

Expires 2035-05-15

Read SEC document
May 15, 2025 Filed May 19, 2025 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 577 $0.00 $0.00
Disclosure

SEC source: 0000313616-25-000129 · wk-form4_1747688454.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,085.643

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 25, 2025 Filed Apr 29, 2025 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 221.592 $197.14 Strike: $0.00 $43,684.65
Disclosure

SEC source: 0000313616-25-000099 · wk-form4_1745960419.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,595.643

Underlying: Common Stock · 221.592 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
January 31, 2025 Filed Feb 4, 2025 22:36 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 186.386 $222.74 Strike: $0.00 $41,515.62
Disclosure

SEC source: 0000313616-25-000037 · wk-form4_1738708594.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,374.051

Underlying: Common Stock · 186.386 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
October 25, 2024 Filed Oct 28, 2024 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 168.996 $245.39 Strike: $0.00 $41,469.93
Disclosure

SEC source: 0000313616-24-000238 · wk-form4_1730149284.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,187.664

Underlying: Common Stock · 168.996 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 26, 2024 Filed Jul 29, 2024 21:00 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 151.251 $273.19 Strike: $0.00 $41,320.26
Disclosure

SEC source: 0000313616-24-000201 · wk-form4_1722286812.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,018.668

Underlying: Common Stock · 151.251 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 24, 2024 Filed Jul 26, 2024 23:08 UTC OPKO HEALTH, INC. OPK · Entity 4891 GrantCommon Stock 500,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-087032 · ownership.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 589,600

F1 · security: Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The restricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionDirector stock option (right to buy) · Derivative 3,289 $0.00 Strike: $52.56 $0.00
Disclosure

SEC source: 0000313616-24-000184 · wk-form4_1721163667.xml · derivative · entry 4

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,289 shares

Expires 2024-07-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 15, 2024 Filed Jul 16, 2024 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 Tax withholdingCommon Stock 703 $246.23 $173,099.69
Disclosure

SEC source: 0000313616-24-000184 · wk-form4_1721163667.xml · nonDerivative · entry 2

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,780.417

Read SEC document
July 15, 2024 Filed Jul 16, 2024 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionCommon Stock 3,289 $52.56 $172,869.84
Disclosure

SEC source: 0000313616-24-000184 · wk-form4_1721163667.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,483.417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2024 Filed May 17, 2024 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,081 $0.00 Strike: $263.46 $0.00
Disclosure

SEC source: 0000313616-24-000158 · wk-form4_1715979692.xml · derivative · entry 3

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,081

Underlying: Common Stock · 1,081 shares

Expires 2034-05-15

Read SEC document
May 15, 2024 Filed May 17, 2024 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 390 $0.00 $0.00
Disclosure

SEC source: 0000313616-24-000158 · wk-form4_1715979692.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,194.417

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 26, 2024 Filed Apr 29, 2024 21:01 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 167.832 $246.58 Strike: $0.00 $41,384.01
Disclosure

SEC source: 0000313616-24-000126 · wk-form4_1714424504.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,867.417

Underlying: Common Stock · 167.832 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
January 26, 2024 Filed Jan 30, 2024 22:05 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 172.603 $233.00 Strike: $0.00 $40,216.50
Disclosure

SEC source: 0000313616-24-000015 · wk-form4_1706652292.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,699.585

Underlying: Common Stock · 172.603 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:26 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 400,000 $0.94 $376,000.00
Disclosure

SEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 4

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 20,327,814

F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:26 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 100,000 $0.93 $93,000.00
Disclosure

SEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 3

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 19,927,814

F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:26 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 33,300 $0.91 $30,303.00
Disclosure

SEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 2

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 19,827,814

F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
January 05, 2024 Filed Jan 5, 2024 22:26 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 17,000 $0.87 $14,790.00
Disclosure

SEC source: 0000950170-24-002542 · ownership.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 19,794,514

F1 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 27, 2023 Filed Oct 30, 2023 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 216.382 $187.88 Strike: $0.00 $40,653.85
Disclosure

SEC source: 0000313616-23-000273 · wk-form4_1698699762.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,526.982

Underlying: Common Stock · 216.382 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionDirector stock option (right to buy) · Derivative 3,490 $0.00 Strike: $50.80 $0.00
Disclosure

SEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · derivative · entry 5

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,490 shares

Expires 2023-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 154.267 $260.07 Strike: $0.00 $40,120.22
Disclosure

SEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · derivative · entry 4

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,488.269

Underlying: Common Stock · 154.267 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 Tax withholdingCommon Stock 682 $260.07 $177,367.74
Disclosure

SEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · nonDerivative · entry 2

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,841.269

Read SEC document
July 28, 2023 Filed Aug 1, 2023 21:02 UTC DANAHER CORP /DE/ DHR · Entity 2871 Exercise / conversionCommon Stock 3,490 $50.80 $177,292.00
Disclosure

SEC source: 0000313616-23-000236 · wk-form4_1690923770.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,523.269

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 18, 2023 Filed May 19, 2023 20:38 UTC OPKO HEALTH, INC. OPK · Entity 4891 GrantStock Option (Right to Buy) · Derivative 800,000 $0.00 Strike: $1.58 $0.00
Disclosure

SEC source: 0001209191-23-031035 · doc4.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2033-05-17

F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 18, 2024.

Read SEC document
May 15, 2023 Filed May 17, 2023 21:05 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 1,194 $0.00 Strike: $226.94 $0.00
Disclosure

SEC source: 0000313616-23-000205 · wk-form4_1684357532.xml · derivative · entry 3

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,194

Underlying: Common Stock · 1,194 shares

Expires 2033-05-15

Read SEC document
May 15, 2023 Filed May 17, 2023 21:05 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 430 $0.00 $0.00
Disclosure

SEC source: 0000313616-23-000205 · wk-form4_1684357532.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,879.002

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
April 28, 2023 Filed May 1, 2023 21:07 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 169.155 $236.91 Strike: $0.00 $40,074.51
Disclosure

SEC source: 0000313616-23-000165 · wf-form4_168297524283210.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,334.002

Underlying: Common Stock · 169.155 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
January 27, 2023 Filed Jan 30, 2023 22:08 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 149.462 $265.98 Strike: $0.00 $39,753.90
Disclosure

SEC source: 0000313616-23-000044 · wf-form4_167511651253709.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,164.847

Underlying: Common Stock · 149.462 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
October 28, 2022 Filed Oct 31, 2022 21:08 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 157.722 $251.80 Strike: $0.00 $39,714.40
Disclosure

SEC source: 0000313616-22-000265 · wf-form4_166725048666290.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,015.385

Underlying: Common Stock · 157.722 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees s/he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 21:12 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantPhantom shares · Derivative 136.139 $291.47 Strike: $0.00 $39,680.43
Disclosure

SEC source: 0000313616-22-000213 · wf-form4_165947472062369.xml · derivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,857.663

Underlying: Common Stock · 136.139 shares

Expires not disclosed

F1 · security: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

F2 · derivative.exercise_price: Upon distribution, the phantom shares convert into shares of Danaher common stock on a one-for-one basis.

F3 · derivative.exercise_date: The reporting person is fully vested in all amounts deferred under the Plan.

F3 · derivative.expiration_date: The reporting person is fully vested in all amounts deferred under the Plan.

F1 · derivative.underlying: Under the terms of the Non-Employee Directors Deferred Compensation Plan (the "Plan") established under the Danaher Corporation 2007 Omnibus Incentive Plan, the reporting person can defer all or part of the cash director fees he is entitled to receive each quarter. Amounts deferred under the plan (which includes dividend accruals on plan balances and may also include cash director fees) are converted into a particular number of notional shares of Danaher common stock, calculated based on the closing price of Danaher's common stock on the quarterly date such amounts otherwise would have been paid. The price shown in Table II, Column 8 above is the closing price per share of the Danaher common stock as reported on the NYSE on the transaction date noted above.

Read SEC document
May 15, 2022 Filed May 17, 2022 21:19 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantDirector stock option (right to buy) · Derivative 929 $0.00 Strike: $249.19 $0.00
Disclosure

SEC source: 0000313616-22-000151 · wf-form4_165282233457815.xml · derivative · entry 3

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 929

Underlying: Common Stock · 929 shares

Expires 2032-05-15

Read SEC document
May 15, 2022 Filed May 17, 2022 21:19 UTC DANAHER CORP /DE/ DHR · Entity 2871 GrantCommon Stock 372 $0.00 $0.00
Disclosure

SEC source: 0000313616-22-000151 · wf-form4_165282233457815.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,836.524

F1 · shares: On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.

Read SEC document
May 10, 2022 Filed May 12, 2022 01:01 UTC OPKO HEALTH, INC. OPK · Entity 4891 PurchaseCommon Stock 89,600 $2.79 $250,396.16
Disclosure

SEC source: 0001209191-22-028425 · doc4.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,600

Read SEC document
May 09, 2022 Filed May 12, 2022 01:01 UTC OPKO HEALTH, INC. OPK · Entity 4891 GrantStock Option (Right to Buy) · Derivative 34,923 $0.00 Strike: $3.20 $0.00
Disclosure

SEC source: 0001209191-22-028425 · doc4.xml · derivative · entry 2

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,923

Underlying: Common Stock · 34,923 shares

Expires 2032-05-08

F1 · derivative.exercise_date: This option will vest in four equal annual installments beginning May 9, 2023.

Read SEC document
May 09, 2022 Filed Jun 22, 2022 20:42 UTC Amendment OPKO HEALTH, INC. OPK · Entity 4891 GrantCommon Stock 19,777,514 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-038693 · doc4a.xml · nonDerivative · entry 2

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the EAZ ZERAZ TRUST

Disclosed balance after: 19,777,514

F1 · date: This Form 4 amendment is being filed to report the acquisition of shares of the Issuer's common stock by the ZERHOUNI IRREVOCABLE TRUST and the EAZ ZERAZ TRUST, in each case, pursuant to the ModeX Merger (as defined below), inadvertently omitted in the original Form 4.

F4 · price: Received in exchange for 2,250,000 shares of ModeX held directly by the EAZ ZERAZ TRUST in connection with the ModeX Merger.

F5 · ownership.nature: Shares held by the EAZ ZERAZ TRUST for the benefit of the Reporting Person's spouse and children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document
May 09, 2022 Filed Jun 22, 2022 20:42 UTC Amendment OPKO HEALTH, INC. OPK · Entity 4891 GrantCommon Stock 19,777,514 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-038693 · doc4a.xml · nonDerivative · entry 1

Zerhouni Elias A. · CIK 0001478398 · Director · Vice Chairman and President

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by the ZERHOUNI IRREVOCABLE TRUST

Disclosed balance after: 19,777,514

F1 · date: This Form 4 amendment is being filed to report the acquisition of shares of the Issuer's common stock by the ZERHOUNI IRREVOCABLE TRUST and the EAZ ZERAZ TRUST, in each case, pursuant to the ModeX Merger (as defined below), inadvertently omitted in the original Form 4.

F2 · price: Received in exchange for 2,250,000 shares of ModeX Therapeutics, Inc., a Delaware corporation ("ModeX"), held directly by the ZERHOUNI IRREVOCABLE TRUST in connection with the Agreement and Plan of Merger, dated as of May 9, 2022, by and among the Issuer, ModeX, Orca Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, and Gary J. Nabel, solely in his capacity as sellers' representative, pursuant to which ModeX became a wholly owned subsidiary of the Issuer (the "ModeX Merger").

F3 · ownership.nature: Shares held by the ZERHOUNI IRREVOCABLE TRUST for the benefit of the Reporting Person and his children and remoter issue, as well as certain qualifying charitable organizations, and for which an independent trustee has been appointed. The independent trustee has delegated investment authority of the trust to the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.